Skip to main content
. 2007 Apr 5;56(10):1637–1644. doi: 10.1007/s00262-007-0310-7

Table 2.

Characteristics of patients included into the study

All patients Dose level I Dose level II Dose level III Dose level IV Dose level V
No. of patients N = 15 N = 3 N = 1 N = 4 N = 5 N = 2
Median age in years (range) 57 (48–71) 60 (51–68) 71 60 (49–71) 53 (48–68) 54.5 (48–61)
Male/female 9/6 3/0 1/0 1/3 3/2 1/1
UICC stage I 1 1
IIB 5 3 1 1
IIIA 1 1
IIB 4 1 3
IV 4 1 2 1